Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Sygnature Discovery has acquired Peak Proteins Ltd. Following an extensive partnership between the two companies, this deal will enable seamless integration of protein production and related structure determination projects within Sygnature. ...
read more
On July 18, 2022, Neil Jones joined Aenova as the new Chief Commercial Officer (CCO) of Aenova Group.
read more
Wednesday, March 28, 2018
MedPharm announced a multi-million dollar investment by Ampersand Capital Partners.
read more
Elligo Health Research announced the acquisition of Root Health, an AI virtual assistant for clinical research. The acquisition of Root Health adds to Elligo’s commitment of building a technology-forward, integrated healthcare-enabling research ...
read more
Coriolis Pharma, a globally operating service provider in formulation research and development of biopharmaceutical drugs, announced the expansion of its ATMP development facilities under biosafety level S2 (BSL2).
read more
Mylan announced a global collaboration with Gilead Sciences to expand access to the investigational antiviral remdesivir for the potential treatment of COVID-19.
read more
Wednesday, October 21, 2020
Recombinetics has partnered with American Preclinical Services in a first of its kind study to improve Glioblastoma outcomes.
read more
Cambrex has completed the expansion of a new 150m2 research and development laboratory at its site in Paullo, Milan, Italy.
read more
Monday, November 11, 2013
Celerion is pleased to announce the appointment of Clayton Dehn as Executive Director, Metabolic Diseases. Mr. Dehn will lead the expansion of Celerion’s current capabilities that support early Proof-of-Concept in the development of diabetes, obesity...
read more
Thursday, December 07, 2023
Experic, a contract development and manufacturing organization (CDMO) and provider of clinical trial supply services, has unveiled the incorporation of a Harro Höfliger Modu-C CS Containment system at its New Jersey facility.
read more
Monday, December 18, 2023
Checkpoint Therapeutics, Inc. disclosed that the FDA issued a Complete Response Letter (CRL) in connection with the cosibelimab biologic license application (BLA) intended for the treatment of individuals with metastatic or locally advanced cutaneous...
read more
ERT has announced the acquisition of APDM Wearable Technologies, a next-generation provider of wearables and digital biomarkers.
read more
Monday, September 07, 2020
PPD and LT have entered into a collaboration to expand and enhance lupus clinical research for PPD’s pharmaceutical and biotech customers.
read more
Panel to leverage their collective expertise to create monthly and annual reports to explore future contingencies effecting the global pharma industry
read more
Wednesday, February 06, 2019
ICON announced the release of a new drug safety reporting solution based on an innovative cloud-based system, featuring automated and configurable business rules.
read more